{"transactions":[{"id":1739668,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":108230,"kind":"person","name":"KAY E GERALD","position":1,"cik":"0001053310","reported_name":"KAY E GERALD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman & President"}}],"security":"Stock Option (right to buy)","published_at":"2023-11-16T21:13:09.000Z","date":"2023-03-20","kind":"other","planned":false,"acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"None of the Options were vested at the time of passing of the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vested over three years beginning of the first year anniversary noted herein."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"None of the Options were vested at the time of passing of the Reporting Person."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F6","text":"None of the Options were vested at the time of passing of the Reporting Person."}],"balance_after":0,"derivative":{"exercise_price":0.45,"exercise_date":"2023-11-09","expiration_date":"2023-03-20","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001345281-23-000006","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528123000006/primary_doc.xml","form_type":"5"}},{"id":1739667,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":108230,"kind":"person","name":"KAY E GERALD","position":1,"cik":"0001053310","reported_name":"KAY E GERALD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman & President"}}],"security":"Stock Option (right to buy)","published_at":"2023-11-16T21:13:09.000Z","date":"2023-03-20","kind":"other","planned":false,"acquired":false,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Includes 43,333 shares that were not vested at the time of the Reporting Person's passing."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vested over three years beginning of the first year anniversary noted herein."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Due to the passing of the Reporting Person, the Expiration Date is one year from the date of death."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"Includes 43,333 shares that were not vested at the time of the Reporting Person's passing."}],"balance_after":0,"derivative":{"exercise_price":1.045,"exercise_date":"2022-11-03","expiration_date":"2024-03-20","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001345281-23-000006","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528123000006/primary_doc.xml","form_type":"5"}},{"id":1739666,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":108230,"kind":"person","name":"KAY E GERALD","position":1,"cik":"0001053310","reported_name":"KAY E GERALD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman & President"}}],"security":"Stock Option (right to buy)","published_at":"2023-11-16T21:13:09.000Z","date":"2023-03-20","kind":"other","planned":false,"acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Includes 33,333 shares that were not vested at the time of the Reporting Person's passing."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vested over three years beginning of the first year anniversary noted herein."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Due to the passing of the Reporting Person, the Expiration Date is one year from the date of death."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"Includes 33,333 shares that were not vested at the time of the Reporting Person's passing."}],"balance_after":0,"derivative":{"exercise_price":0.72,"exercise_date":"2021-11-04","expiration_date":"2024-03-20","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001345281-23-000006","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528123000006/primary_doc.xml","form_type":"5"}},{"id":1739665,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":108230,"kind":"person","name":"KAY E GERALD","position":1,"cik":"0001053310","reported_name":"KAY E GERALD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman & President"}}],"security":"Stock Option (right to buy)","published_at":"2023-11-16T21:13:09.000Z","date":"2023-03-20","kind":"other","planned":false,"acquired":false,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vested over three years beginning of the first year anniversary noted herein."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Due to the passing of the Reporting Person, the Expiration Date is one year from the date of death."}],"balance_after":0,"derivative":{"exercise_price":0.23,"exercise_date":"2020-05-24","expiration_date":"2024-03-20","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001345281-23-000006","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528123000006/primary_doc.xml","form_type":"5"}},{"id":1739664,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":108230,"kind":"person","name":"KAY E GERALD","position":1,"cik":"0001053310","reported_name":"KAY E GERALD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman & President"}}],"security":"Common Stock","published_at":"2023-11-16T21:13:09.000Z","date":"2023-03-20","kind":"other","planned":false,"acquired":false,"shares":853022,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"As sole member of LLC or Trustee of Trusts"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Includes (i) 819,628 shares registered to the name of EGK LLC, an entity the Reporting Person was the sole member of and (ii) 16,697 shares held in each of the Riva Grantor Trust and Christina Kay Grantor Trust whereas the Reporting Person was the Trustee."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Includes (i) 819,628 shares registered to the name of EGK LLC, an entity the Reporting Person was the sole member of and (ii) 16,697 shares held in each of the Riva Grantor Trust and Christina Kay Grantor Trust whereas the Reporting Person was the Trustee."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001345281-23-000006","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528123000006/primary_doc.xml","form_type":"5"}},{"id":1739663,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":108230,"kind":"person","name":"KAY E GERALD","position":1,"cik":"0001053310","reported_name":"KAY E GERALD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman & President"}}],"security":"Common Stock","published_at":"2023-11-16T21:13:09.000Z","date":"2023-03-20","kind":"other","planned":false,"acquired":false,"shares":4299533,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001345281-23-000006","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528123000006/primary_doc.xml","form_type":"5"}},{"id":2120341,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":108230,"kind":"person","name":"KAY E GERALD","position":1,"cik":"0001053310","reported_name":"KAY E GERALD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman & President"}}],"security":"Stock Option (right to buy)","published_at":"2022-11-10T23:39:23.000Z","date":"2022-11-09","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Exercise Price of the Stock Option will be 110% the closing prices of the Issuer's Common Stock on the fifth trading day after the filing of the Issuer's Quarterly Report on Form 10-Q for the period ended September 30, 2022, with the Securities and Exchange Commission."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable in three equal annual installments with the first installment vesting on November 9, 2023."}],"balance_after":100000,"derivative":{"expiration_date":"2027-11-09","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001053310-22-000003","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000105331022000003/primary_doc.xml","form_type":"4"}},{"id":2275206,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":108230,"kind":"person","name":"KAY E GERALD","position":1,"cik":"0001053310","reported_name":"KAY E GERALD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman & President"}}],"security":"Stock Option (right to buy)","published_at":"2022-05-11T18:37:26.000Z","date":"2022-05-06","kind":"exercise","acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested 50% (125,000) on grant date (May 24, 2019) and in three equal annual installments for the remaining 50% (125,000) beginning on May 24, 2020 and ending May 24, 2022."}],"balance_after":150000,"derivative":{"exercise_price":0.23,"expiration_date":"2024-05-24","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001053310-22-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000105331022000002/primary_doc.xml","form_type":"4/A","original_submission_date":"2022-05-06"}},{"id":2275205,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":108230,"kind":"person","name":"KAY E GERALD","position":1,"cik":"0001053310","reported_name":"KAY E GERALD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman & President"}}],"security":"Common Stock","published_at":"2022-05-11T18:37:26.000Z","date":"2022-05-06","kind":"exercise","acquired":true,"shares":100000,"price":0.23,"value":23000.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Form 4 is being amended to correct the Transaction Code in Table 1 and to include the previously inadvertently omitted disclosure in Table II."},{"field":"security","element":"securityTitle","label":"F2","text":"100,000 common stock shares acquired upon exercise of stock option grant dated May 24, 2019."}],"balance_after":5345889,"source":{"system":"sec-edgar","filing":"0001053310-22-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000105331022000002/primary_doc.xml","form_type":"4/A","original_submission_date":"2022-05-06"}},{"id":2279728,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":108230,"kind":"person","name":"KAY E GERALD","position":1,"cik":"0001053310","reported_name":"KAY E GERALD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman & President"}}],"security":"Common Stock","published_at":"2022-05-06T21:08:35.000Z","date":"2022-05-06","kind":"grant","acquired":true,"shares":100000,"price":0.23,"value":23000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"100,000 common stock shares acquired upon exercise of stock option grant dated May 24, 2019."}],"balance_after":5345889,"source":{"system":"sec-edgar","filing":"0001053310-22-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000105331022000001/primary_doc.xml","form_type":"4"}},{"id":2525056,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":108230,"kind":"person","name":"KAY E GERALD","position":1,"cik":"0001053310","reported_name":"KAY E GERALD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman & President"}}],"security":"Stock Option (right to buy)","published_at":"2021-11-04T14:52:29.000Z","date":"2021-11-03","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Exercise Price of the Stock Option will be 110% of the closing price of the Issuer's Common Stock five trading days after the filing of the Issuer's Quarterly Report on Form 10-Q for the period ended September 30, 2021, with the Securities and Exchange Commission."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable in three equal annual installments with the first installment vesting on November 3, 2022."}],"balance_after":65000,"derivative":{"expiration_date":"2026-11-03","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001053310-21-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000105331021000001/primary_doc.xml","form_type":"4"}},{"id":2971697,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":108230,"kind":"person","name":"KAY E GERALD","position":1,"cik":"0001053310","reported_name":"KAY E GERALD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman & President"}}],"security":"Stock Option (right to buy)","published_at":"2020-11-20T22:13:23.000Z","date":"2020-11-04","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in three equal annual installments beginning on November 4, 2021."}],"balance_after":100000,"derivative":{"exercise_price":0.72,"expiration_date":"2025-11-04","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001345281-20-000007","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528120000007/primary_doc.xml","form_type":"4"}},{"id":3509225,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":108230,"kind":"person","name":"KAY E GERALD","position":1,"cik":"0001053310","reported_name":"KAY E GERALD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman & President"}}],"security":"Stock Option (right to buy)","published_at":"2019-05-29T20:49:18.000Z","date":"2019-05-24","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 50% (125,000) on grant date (May 24, 2019) and in three equal annual installments for the remaining 50% (125,000) beginning on May 24, 2020."}],"balance_after":250000,"derivative":{"exercise_price":0.233,"expiration_date":"2024-05-24","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001053310-19-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000105331019000001/primary_doc.xml","form_type":"4"}},{"id":3725395,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":108230,"kind":"person","name":"KAY E GERALD","position":1,"cik":"0001053310","reported_name":"KAY E GERALD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-12-19T23:45:32.000Z","date":"2018-12-19","kind":"grant","acquired":true,"shares":100000,"price":0.1,"value":10000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"100,000 common stock shares acquired upon exercise of stock option grant dated June 2, 2015."}],"balance_after":5262556,"source":{"system":"sec-edgar","filing":"0001053310-18-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000105331018000001/primary_doc.xml","form_type":"4"}}]}